<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reduced levels of human myeloid nuclear differentiation antigen (MNDA) gene transcripts have been detected in both familial and <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Numerous reports implicate elevated <z:mpath ids='MPATH_3'>apoptosis</z:mpath>/programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> ligands and their receptors in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MNDA and related proteins contain the pyrin domain that functions in signaling associated with programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We tested the hypothesis that MNDA is involved in the regulation of programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> in human myeloid hematopoietic cells </plain></SENT>
<SENT sid="4" pm="."><plain>Clones of K562 cells (MNDA-null) that expressed ectopic MNDA protein were established using retroviral transduction </plain></SENT>
<SENT sid="5" pm="."><plain>MNDA-expressing K562 clones were resistant to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inducing ligand (TRAIL)-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, but were not protected from programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> induced with <z:chebi fb="0" ids="50902">genotoxic agents</z:chebi> or <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>MNDA protein expression assessed in control and intermediate and high-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrows showed several patterns of aberrant reduced MNDA </plain></SENT>
<SENT sid="7" pm="."><plain>These variable patterns of dysregulated MNDA expression may relate to the variable pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We propose that MNDA has a role regulating programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> in myeloid progenitor cells, and that its down-regulation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is related to granulocyte-macrophage progenitor cell sensitivity to TRAIL-induced programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>